chrisvoncsefalvay/vaers-outcomes huggingface dataset:
5 people she knew were vaccinated and died; This is a spontaneous report received from Pfizer sponsored program.   A Non-contactable female consumer reporting same event(s) under the same suspect product(s) for 5 patients. This is the second of five reports:  A patient of unspecified age and gender received bnt162b2 (COMIRNATY), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  She also stated during conversation that 5 people she knew were vaccinated and died. She did not have any other information.  The patient died on an unspecified date.  It was not reported if an autopsy was performed.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER_INC-202101451919 same reporter/drug/event, different PTs; Reported Cause(s) of Death: 5 people she knew were vaccinated and died.
I had mild to intense sensitivity to light within 5 hours of the vaccine. Around 9pm the night of my second and final dose, I could not settle. I tried to sleep under my usual schedule and routine. I kept waking up for no apparent reason. I felt like my body would rest but my brain never actually fell into sleep. I was not able to achieve REM sleep until around 7am. I woke up late around 11am feeling like I passed out from sleep deprivation. I woke feeling like I had a strange "hang over". I felt dizzy and light headed. I had a general feeling of being unwell. I had a pressure in my head above my temples that circled my head to the back of my crown area.
Patient broke out into a measles-like rash almost exactly 10 days after receiving the vaccine. When taken to the doctor they confirmed that it was a vaccine rash.
Right arm is swollen, red, and warm from elbow to shoulder. Pt has high temperature: 102.5 when measured on 10/23/2019
Case number PHEH2011US02198 is an initial spontaneous report received from a nurse on 05 Aug 2011 with follow-up received on 06 Sep 2011. This report refers to a 19-year-old female patient. She was given only the MenCWY liquid conjugate component of MENVEO (batch number: X10030 and expiry date: Sep 2012) intramuscularly on 01 Aug 2011. No adverse event reported following this administration error. The patient was revaccinated with MENVEO on 08 Aug 2011. No adverse event occurred after revaccination. Follow-up received on 06 Sep 2011: Patient demographics updated.
I experienced a breakthrough case of COVID-19 that started with coughing and I later tested positive for COVID-19. I also experienced shortness of breath, fatigue and tiredness.
Before receiving vaccine, patient emphasized verbally that she has had a history of vasovagal reaction to vaccines. Parents were accompanying her. Patient received vaccine at approximately 1:25pm. Patient did not immediately feel faint after the vaccination, and then stepped out to have a seat at the pharmacy waiting area. Patient started to feel faint at approximately 1:30pm. Parents called for a pharmacist and proceeded to elevate her feet and have her lie down on the floor. I asked if patient was feeling any other symptoms, such as chest pain, difficulty breathing, etc. Patient denied feeling any other symptoms other than lightheadedness. I offered to call for an ambulance, but patient and parents denied to call for ambulance. Asked patient and parents to remain in the waiting area for at least another 15 minutes. Patient reported feeling better at approximate 2:08pm before leaving. I advised them to seek immediate medical care if any new symptoms start to develop, especially if there was any chest pain, any new fainting, difficulty breathing, etc. I also advised them to make sure to follow up with the primary medical provider
Started itching all over, started on the way home from receiving flu vaccine. No rash, no hives, no itchy throat, no breathing problems. Lasted through the night. Fine the next day reported to health dept by client on 11/03/06.
Severe feeling of pins and needles, primarily in right leg and foot, sometimes in left leg and foot. Pins and needles sensation constant in right leg and foot, and lasted four months from dose of vaccine. Pins and needles sensation now just occasional in right foot and leg.
A pient experienced a lot of swelling in her arm  after receiving her first dose of GARDASIL 9; This spontaneous report was received from a physician via company representative referring to a 14 year old female patient. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported.     On an unknown date, during a routine checkup, the patient experienced  a lot of swelling in her arm (peripheral swelling ) after receiving her first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (strength, route, dose, frequency, anatomical location, indication, lot # and expiration date were unknown) for prophylaxis.    At the time of the report, the outcome of peripheral swelling was unknown. The reporter did not mention the causality assessment between the event and  hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) vaccination.
Information has been received from a physician concerning a female (and unknown) who, on an unspecified date, was vaccinated with a dose of Gardasil. Subsequently, on an unspecified date, the patient developed redness and pain at the injection site area. The patient sought unspecified medical attention. At the time of the report, the patient's outcome was unknown. No product quality complaint was involved. Additional information has been requested.
Initially developed conjunctivitis.  Proceeded to sore throat and headache by 7/7/11. Fever 7/8-7/9/11. Myalgia onset around 7/7/11 as well.
fever; cough; chills; muscle aches This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PYREXIA (non-serious), outcome "recovered", described as "fever"; COUGH (non-serious), outcome "not recovered", described as "cough"; CHILLS (non-serious), outcome "recovered", described as "chills"; MYALGIA (non-serious), outcome "recovered", described as "muscle aches".  Additional information: Patient received the 1st dose of pfizer covid vaccine and had a reaction: fever, cough, chills, muscle aches for 5 days. Reports ongoing cough. wanting to know if it was safe to get 2nd dose given his reactions to first dose.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
chest pain; Abdominal pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain) and ABDOMINAL PAIN (Abdominal pain) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (chest pain) and ABDOMINAL PAIN (Abdominal pain). At the time of the report, CHEST PAIN (chest pain) and ABDOMINAL PAIN (Abdominal pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported. No treatment information was provided.
developed redness; pain along left nasolabial fold with soreness; nodule and firmness; This is a spontaneous report received from a non-contactable reporter(s) (Physician). Other Case identifier(s): GL-052821-13037 (Galderma).  A 49 year-old female patient received bnt162b2 (BNT162B2), administration date 13Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "rosacea" (unspecified if ongoing); "skin cancer" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Restylane lyft, start date: 23Apr2021, notes: Patient was injected with 1cc total of Restylane Lyft in both cheeks on 23-Apr-2021. Vaccination history included: Covid-19 vaccine (Dose 1, manufacturer unknown), for COVID-19 immunisation. The following information was reported: ERYTHEMA (non-serious) with onset 2021, outcome "recovered" (24Jun2021), described as "developed redness"; PAIN (non-serious) with onset 2021, outcome "recovered" (24Jun2021), described as "pain along left nasolabial fold with soreness"; NODULE (non-serious) with onset 2021, outcome "recovered" (24Jun2021), described as "nodule and firmness".  Additional information: Patient was injected with 1cc total of Restylane Lyft in both cheeks on 23-Apr-2021. On 26Apr2021, patient developed redness, pain along left nasolabial fold with soreness, nodule and firmness. She was treated with a Vitrase injection, Augmentin and a Prednisone taper. The events resolved on 24Jun2021. Pt received the COVID-19 vaccinations on 16Mar2021 and 13Apr2021 manufacturer unknown. Pt had history of skin cancer the vulva area removed two weeks prior to Lyft injection and had been on antibiotics for a vaginal infection post- surgery. She had a history of rosacea. She had no dental work in the past 6-12 months. It is unknown if patient has had any other vaccinations in the past 6-12 months.  No follow-up attempts are possible. No further information is expected.
12:30 - Moderna accidentally given to patient who was originally scheduled for Pfizer booster. Had 2 doses of Pfizer previously this year. No adverse reactions, client notified.
This spontaneous report as received from a certified medical assistant refers to a 10 year old male patient. No information regarding the patient's medical history and concurrent conditions was reported. On 21-APR-2016 at 16:59, the patient was vaccinated at the private doctor's/hospital with the first dose of GARDASIL 9 injection, lot # L044475, expiration date: 12-MAY-2017, intramuscularly in the right arm, (dose was not provided). There were no concomitant medications reported. It was stated that the vaccine was purchased with public funds. The certified medical assistant also reported that the vaccine underwent a temperature excursion of 34 degrees Fahrenheit for a total time of 65 hours. No previous temperature excursion was reported. The call was not because of a data logger. No adverse events, signs or symptoms were reported. No product quality complaint (PQC) was involved. The patient had no illness at the time of vaccination. This is one of several reports received from the same reporter. Additional information is not expected as all required correspondence has been received.
No additional AE information; temperature excursion; Information has been received from an administrator referring to a 19 months old patient of unknown gender. Information of concomitant therapy, pertinent medical history and drug reactions/allergies was not reported.  On 07-APR-2021, the patient was administered improperly stored measles, mumps, and rubella (wistarra 27-3) virus vaccine, live(M-M-R II) (lot # was reported as S028915, expiration date was reported as 16-SEP-2021, strength, dose, frequency and route unknown) for prophylaxis (incorrect product storage). No adverse effects were reported.  The stored temperature was 1.48 degree Celsius. The time frame was 0.35 hours on 01-MAR-2021. There was no previous temperature excursion. The temperature excursion was detected by a data logger.  This is one of several cases received from the same reporter. ; Sender's Comments:  US-009507513-2105USA004751:
Got shingles after I got the shots/ suspected vaccination failure; Shingles, two times I had them; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK receipt date: 30-JAN-2023 Reporter comment: This case was reported by a patient via interactive digital media. The patient got the shingles after he/she got the Shingles shots two times, he had shingles and before shots no. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Shaking, sweating, vomiting, body aches, face was swollen and rash around neck
pt recvd vax;t of 102 on 19 & 20jan; crankiness, won't use arm; sleeplessness, not feeding;
pt became listless, but had spells of sobbing; lo grade fever, rash resembling heat rash on chest, poor appetite; coughing, duration 4/5 days; examined by MD;
Pt experienced flu-like symptoms, fever, cough, body aches, erythema at injection site on each arm. Pt took Tylenol and unable to give temp report.
Presented with ongoing SOB since 1/13 (initial dx of Covid): admitted for Covid PNA; CXR  bilateral interstitial pulmonary infiltrates; Labs: D-dimer 2.04; CRP 10.77; Ferritin 866; Tx: Zithromax, Decadron, baricitinib, Rocephin, Vit D3, Lovenox, Singulair, zinc; O2 up to 7 L HFNC; back to room air by d/c; but home on home O2
This spontaneous report was received from a registered nurse concerning a 15 year old female patient. On an unknown date, approximately in September 2011 (over a year and a half ago), the patient was vaccinated with dose 1 of GARDASIL (lot number, expiry date, dose and route unspecified). On 18-MAR-2013, the patient was vaccinated with dose 2 of GARDASIL (lot number, expiry date, dose and route unspecified). No concomitant medications were reported. Additional information has been requested.
As a parent, I am not sure which of the meningitis shots it was. The doctor would know. The reaction is severe pain in the area of the injection. It woke her up during the night. She is unable to move the arm. There is mild swelling but no discoloration. The pain did not begin until approx 24 hours after the shot. No fever.
This is a Spontaneous report from PFIZER Sponsored program from a contactable consumer (Patient's wife). A male patient of an unspecified age received BNT162B2, dose 1 via an unspecified route of administration on Mar2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had a stroke (medically significant) on 2021 with outcome of unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
COVID 19 BIVALENT ADULT VACCINE WAS GIVEN INSTEAD OF PEDIATRIC DOSE. CALLED PT, NO RESPONSE.
Tightness in chest cough, Achy arms, legs.  At 1AM chills, achy arms, legs, head ache low grade fever.  6AM low grade fever, and head ache.  10am fever was gone still had head ache
SPOKE WITH MOTHER AND NOTIFIED HER OF ERROR AND ALSO NOTIFIED DR. AND MY PRACTICE MANAGER AND MEDICATION ERROR PERFORMED
Patient presented to the clinic seeking his Moderna Booster dose, MA vaccinating patient administered 0.5 mL instead of the EUA authorized 0.25 mL dose.
1st dose on 13Mar2019, 2nd dose on 23Sep2021; This case was reported by a physician via call center representative and described the occurrence of drug dose administration interval too long in a 69-year-old male patient who received Herpes zoster (Shingrix) (batch number 99C3K, expiry date 31st January 2023) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 13th March 2019 with batch number ZP3P9 and expiry date 10th September 2021).   On 23rd September 2021, the patient received the 2nd dose of Shingrix. On 23rd September 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK receipt date: 14-Sept-2022 Reporter's comment: The reporter consented to follow-up. Additional supportive information: The patient received 2nd dose of possible Shingrix later than the recommended interval, which led to lengthening of vaccine schedule. As it was reported that possible Shingrix vaccine therefore Shingrix vaccine was coded as suspect.
I26.99 ACUTE PULMONARY EMBOLISM 8/30/2022 ASCITES J96.00 ACUTE RESPIRATORY FAILURE 8/8/2022 ASCITES J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 8/30/2022 ASCITES I26.99 ACUTE PULMONARY EMBOLISM 8/30/2022 LOCULATED PLEURAL EFFUSION J96.00 ACUTE RESPIRATORY FAILURE 8/8/2022 LOCULATED PLEURAL EFFUSION J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 8/30/2022 LOCULATED PLEURAL EFFUSION I26.99 ACUTE PULMONARY EMBOLISM 8/30/2022 OVARIAN CANCER, UNSPECIFIED SIDE J96.00 ACUTE RESPIRATORY FAILURE 8/8/2022 OVARIAN CANCER, UNSPECIFIED SIDE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 8/30/2022 OVARIAN CANCER, UNSPECIFIED SIDE I26.99 ACUTE PULMONARY EMBOLISM 8/30/2022 COMPLETE SMALL BOWEL OBSTRUCTION J96.00 ACUTE RESPIRATORY FAILURE 8/8/2022 COMPLETE SMALL BOWEL OBSTRUCTION J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 8/30/2022 COMPLETE SMALL BOWEL OBSTRUCTION I26.99 ACUTE PULMONARY EMBOLISM 8/30/2022 ASCITES J96.00 ACUTE RESPIRATORY FAILURE 8/8/2022 ASCITES J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 8/30/2022 ASCITES
Pt is approximately 5 weeks pregnant with ectopic pregnancy and was vaccinated for covid. Pt admitted for ectopic pregnancy and was covid positive
Patient has memory issues that were unknown to the pharmacy. He asked for a COVID vaccine and said that he had not had any vaccines since last year and that this would be his first vaccine. He was given the Moderna COVID vaccine and 30-45 min later his daughter called and said he had already been fully vaccinated months earlier. No adverse reactions had happened at time of the phone call.
8hrs after vaccination - arm swelling and soreness After 15 hours-nausea and headache, low grade fever, chills After 24 hours was not able to stand for more than 3 minutes without feeling extremely lightheaded and needed to lie down. Mild headache, nausea, fatigue, body ache and arm stillness were present during this timeThis lasted about 4hrs.   After 30 hours still arm soreness and swelling and all other symptoms are very mild
Information has been received from a registered nurse concerning a 20 month old male patient who was vaccinated on 27OCT2003 with a dose of varicella virus vaccine live. One day prior to chickenpox break through, on 13NOV2003 the patient developed a fever. The patient presented to the doctor office on 14NOV2003, with 5 to 6 pox over torso, and some on arm and face. It was noted that the patient had no treatment. It was also noted that the patient's outcome was not recovered. The nurse also stated that the varicella virus vaccine live had a temperature exposure during a hurricane and this was the vaccine that had the break through. No product quality complaint was involved. It was noted that a female and a male patient from the same source, had similar experiences. Additional information has been requested.
Left arm area where DTAP (5th ) dose administered swollen, hot to touch, painful, no fever, child fine otherwise appetite slightly different.
2 days after administration of rotateq child developed fever to 102, and a few episodes of loose stool and vomiting-- report being filed at mom's request
Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Headache-Medium, Systemic: Nausea-Medium
Tingling and numbness in lower and upper extremities on 8-14-10 difficulty walking increased until I could not walk at all-IVIG treatment 8-27-10 to 8-31-10, symptoms returned 9-20-10 until 10-5-10 and on 10-6-10 returned to doctor for IVIG again 10-6-10 to 10-8-10, also had physical therapy from 9-1-10 to 3-30-11, and on IVIG schedule every 4 weeks.
This spontaneous report as received from a medical assistant refers to multiple unspecified patients of unknown age and gender. On an unknown date, the patients were vaccinated subcutaneously with the unknown dose of VARIVAX (Merck) (lot number and expiration date not reported). The reporter stated that the administered doses were stored improperly. There were no adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient reported becoming hot and dizzy within a few minutes of receiving the vaccine. She was escorted to the ED via stretcher.
Patient states after dose 2 of Moderna her arm was "frozen", unable to move, very painful. (SIRVA)
frequency: 21 days on then 7 days off. patient was hospitalized on 10/11/2023 due to reaction to either flu and/or covid vaccination shot that was administered on 10/09/2023. patient was released from hospital on 10/17; his last dose of lenalidomde was taken approximately 10/01/2023. unknown if pt has resumed taking lenalidomide. oncologist is aware of hospitalization. no other information provided.
Redness on right arm and feeling weak. Symptoms worse 8/31/18 and patient improved 9/2.
pain in her left arm where the shot was given; This is a spontaneous report from a contactable consumer (the patient) from a Pfizer-sponsored program. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number not provided), via an unspecified route of administration in the left arm on 23Jan2021 (age at vaccination unknown) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had the first dose of the vaccine on 23Jan2021 and still had pain in her left arm where the shot was given. The patient's second dose will be on 18Feb2021. The clinical outcome of pain in her left arm where the shot was given was not recovered.   Information about batch/lot number has been requested.
pt's mother called stating he went to hospital er for dehydration on friday was given iv fluids and zofran, nausea and vomiting continued and was brought back to hospital on sunday where he is now, ct scan done and awaiting gastro consult
Case number PHEH2015US003117, is an initial spontaneous report received from a medical assistant on 10 Feb 2015. This report refers to a 6 month old male patient. Historical condition and concomitant medication were not reported. By mistake, the patient was vaccinated with MENVEO (batch number: A14071) intramuscularly on 05 Feb 2015 instead of the schedule date of 07 Feb 2015. No adverse event was reported following this administration error (inappropriate schedule of vaccine administered).
Persistent Mental malaise or "brain fog". Prior to the first two series vaccinations, my mental focus was sharp and energetic in spite of the long term recovery from my liver transplant. Between March 19, 2019 and circa March 2021, I was mentally energetic and alert. After the booster vaccine was adminstered on 6/30.2022 (by Pharmacy), the symptoms worsened. Since July 2022, I have had difficulty concentrating especially when reading. I have difficulty focusing for long term periods of time.